Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

Journal of Hepatology

Volumn 29, Issue 6, 1998, Pages 990-993

  Burak, Kelly W ^a,b   Urbanski, Stefan J ^a   Swain, Mark G ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoimmune hepatitis; Liver biopsy; Methotrexate

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; LIVER ENZYME; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CASE REPORT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LIVER BIOPSY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032403227     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80128-1     Document Type: Article

References (21)

1. 1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334: 897-903.
2. 2. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with anti-liver/ kidney microsome antibody type 1: a second type of "autoimmune" hepatitis. Hepatology 1987; 7: 1333-9.
3. 3. Sanchez-Urdazpal LS, Czaja AJ, van Hoek B, Krom RAF, Wiesner RH. Prognostic features and role of liver transplantation in severe corticosteroid-treated chronic active hepatitis. Hepatology 1992; 15: 215-21.
4. 4. Johnson PJ. Treatment of autoimmune hepatitis. Gut 1997; 41: 3-4.
5. 5. Johnson PJ, McFarlane IG, Williams R. Azathioprine for long-term maintenance of remission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-63.
6. 6. Johnson PJ, McFarlane IG Meeting Report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
7. 7. Mistilis SP, Vickers CR, Darroch MH, McCarthy SW Cyclosporine, a new treatment for autoimmune chronic active hepatitis. Med J Aust 1985; 143: 463-5.
8. 8. Sherman KE, Narkewicz M, Pinto PC. Cyclosporine in the management of corticosteroid-resistent type 1 autoimmune chronic active hepatitis. J Hepatol 1994; 21: 1040-7.
9. 9. Van Thiel DH, Wright H, Carroll P, Abu-Elmagd K, Rodriguez-Rio H, McMichael J, et al. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-labelled preliminary trial. Am J Gastroenterol 1995; 90: 771-6.
10. 10. Kanzler S, Gerken G, Kienes HP, Meyer KH, Lohse AW. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis: report of three cases. Z Gastroenterol 1997; 35: 571-8.
11. 11. Simko V, Shoukry M, Prego V. Ursodeoxycholic therapy in chronic liver disease: a meta-analysis in primary biliary cirrhosis and in chronic hepatitis. Am J Gastroenterol 1994; 89: 392-8.
12. 12. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991; 101: 1332-8.
13. 13. Kaplan MM, Schmid C, McKusick A, Provenzale D, Sharma A, Sepe T. Double-blind trial of methotrexate (MTX) versus colchicine (COLCH) in primary biliary cirrhosis (PBC) [abstract]. Hepatology 1993; 18: 176A.
14. 14. Kaplan MM, Dickstein G, Schmid C. Methotrexate (MTX) improves histology in primary biliary cirrhosis (PBC) [abstract]. Hepatology 1994; 20: 152A.
15. 15. Kaplan MM, DeLellis RA, Wolfe H. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Ann Intern Med 1997; 126: 682-8.
16. 16. Knox TA, Kaplan MM. Treatment of primary sclerosing cholangitis with oral methotrexate. Am J Gastroenterol 1991; 86: 546-52.
17. 17. Knox TA, Kaplan MM. A double blind, controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis. Gastroenterology 1994; 106: 494-9.
18. 18. Knox TA, Kaplan MM, Gelfand JA, Wolff SM. Methotrexate treatment of idiopathic granulomatous hepatitis. Ann Intern Med 1995; 122: 592-5.
19. 19. Crostein BN, Naime D. Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993; 92: 2675-82.
20. 20. Sharma A, Provenzale D, McKuick A, Kaplan MM. Interstitial pneumonitis after low-dose methotrexate in primary biliary cirrhosis. Gastroenterology 1994; 107: 266-70.
21. 21. Kevat S, Ahern M, Hall P. Hepatoxicity of methotrexate in rheumatic diseases. Med Toxicol 1988; 3: 197-208.